Symposium
“Intelligent Oncology – The Potential of AI to Control Cancer“
MISSION
Bringing together experts from various disciplines to explore the latest advances in AI-assisted cancer research. Our goal is to promote collaboration between researchers, physicians, industry leaders, and other visionaries in the field. By sharing knowledge and expertise, we aim to discover new ways to control cancer through the power of AI.
–
AIM OF THE CONFERENCE
The theme of the conference is Intelligent Oncology, focusing on harnessing the power of AI to control cancer. Our aim is to present cutting-edge research and innovative approaches in cancer diagnosis, prognosis, and treatment. We aim to identify new research directions, foster collaborations between academia and industry, and facilitate the translation of research findings into clinical practice. By connecting experts in the field, we aim to accelerate progress towards more effective and personalized cancer treatment.
–
AREAS OF FOCUS
AI in cancer diagnosis/treatment
Computational methods for cancer research
Precision medicine with AI
Ethical, regulatory and governance issues of AI for health
Clinical translation of AI health interventions
Innovative AI technologies/platforms
Interdisciplinary collaborations in cancer
–
SCIENTIFIC BOARD
Prof. Dr. Mascha Binder
CRIION Scientific Director Clinical Oncology & University Hospital Basel
Prof. Dr. Joschka Boedecker
CRIION Scientific Director AI & Department of Computer Science, University of Freiburg
Prof. Dr. Dr. Melanie Börries
CRIION Scientific Director Systems Medicine & Medical Center, University of Freiburg
Prof. Dr. Robert Zeiser
CRIION Scientific Director Translational Oncology & Medical Center, University of Freiburg
Prof. em. Dr. Dr. h.c. mult. Roland Mertelsmann
CEO Mertelsmann Foundation & Medical Center, University of Freiburg
Dr. Maria Kalweit
CRIION Head of Applied AI Research & Department of Computer Science, University of Freiburg
Dr. Gabriel Kalweit
CRIION Head of Fundamental AI Research & Department of Computer Science, University of Freiburg
–
PRELIMINARY PROGRAM 2024
Session 1: Understanding Cancer Through AI and Computational Biology
This session will explore how AI and computational biology can improve our understanding of cancer.
Session 2: Translating AI and Computational Biology into Clinical Applications
In this session, speakers will discuss the challenges and opportunities of translating AI and computational biology into clinical practice for cancer diagnosis, prognosis, and treatment.
Session 3: Ethical, Regulatory and Governance Considerations
This session will examine ethical, regulatory and governance issues related to the development and deployment of AI and computational biology-powered cancer therapies.
–
REGISTRATION
–
–
RECORDINGS OF THE PAST MEETING
–
If you like to receive the password, please contact sina.reis@comeed.ch
–
IMPRESSIONS OF THE PAST MEETING
–
–
To get the password please contact: sina.reis@comeed.ch
SPEAKERS 2022

–
Dr. Victor Greiff
University of Oslo, Norway
–

–
Dr. Ignacio Mastroleo
University of Buenos Aires, Argentina
–

–
Dr. Jan Moritz Middeke
University Hospital Dresden, Germany
–

–
Prof. Olaf Ronneberger
Google DeepMind, United Kingdom
–

–
Dr. Itay Tirosh
Weizmann Institute, Israel
–

–
Prof. Lena Maier-Hein
German Cancer Research Center, Germany
–

–
Prof. Christoph Merten
EPFL, Switzerland
–

–
Dr. Quaid Morris
Memorial Sloan Kettering Cancer Center, USA
–

–
Dr. Nikolaus Schultz
Memorial Sloan Kettering Cancer Center, USA
–

–
Dr. Adriana Tomic
University of Oxford, United Kingdom
–